Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab [1]

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 761-762

  Bond, Jonathan ^a   Shahdadpuri, Raveen ^a   Mc Mahon, Corrina ^a   O'Marcaigh, Aengus ^a   Cotter, Melanie ^a   Smith, Owen ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; VIRUS DNA; MONOCLONAL ANTIBODY;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; EPSTEIN BARR VIRUS; FAMILY HISTORY; HUMAN; INFANT; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; X LINKED LYMPHOPROLIFERATIVE DISEASE; DRUG COMBINATION; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION; VIRUS LOAD;

ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 35148812994     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21081     Document Type: Letter

References (3)

1. Seemayer TA, Greiner TG, Gross TG, Davis JR, Lanyi A, Sumegi J. X-linked lymphoproliferative disease. In: Goedert JJ, editor. Infectious causes of cancer, targets for intervention. Totowa, NJ: Humana Press; 2000. pp 51-61.
2. Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462-469.
3. Milone MC, Tsai DE, Hodinka RL, Silverman LB, Malbran A, Wasik MA, Nichols KE. Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 2005;105:994-996.